The epidermal growth factor receptor—the prototypic RTK—turns 40

The seminal discovery that the epidermal growth factor receptor (EGFR) possesses intrinsic EGF-stimulated tyrosine kinase activity that serves as a mitogenic signalling mechanism was dependent on two separate lines of research that intersected in the late 1970s and early 1980s, namely studies of retroviral transforming proteins and the identification of growth factor receptor proteins. This historical review outlines the events that ultimately led to the intersection of these two strands of research, resulting from the twin discoveries that many growth factor receptors, including EGFR, are ligand-activated receptor tyrosine kinases (RTKs), and that many retroviral transforming proteins are dysregulated tyrosine kinases that usurp RTK signalling pathways to drive continuous cell proliferation. A French translation of this abstract is available in the supplementary material. This article is part of the discussion meeting issue 'Epidermal growth factor receptor after 40 years'.

Authors

Institutions

Publication Details

Journal
Philosophical Transactions of the Royal Society B Biological Sciences
Published
2026-08-27
DOI
https://doi.org/10.1098/rstb.2024.0495
Primary Topic
HER2/EGFR in Cancer Research
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

The epidermal growth factor receptor—the prototypic RTK—turns 40

Tony Hunter
Philosophical Transactions of the Royal Society B Biological Sciences
HER2/EGFR in Cancer Research
article

The epidermal growth factor receptor—the prototypic RTK—turns 40

Tony Hunter
article en

Abstract

The seminal discovery that the epidermal growth factor receptor (EGFR) possesses intrinsic EGF-stimulated tyrosine kinase activity that serves as a mitogenic signalling mechanism was dependent on two separate lines of research that intersected in the late 1970s and early 1980s, namely studies of retroviral transforming proteins and the identification of growth factor receptor proteins. This historical review outlines the events that ultimately led to the intersection of these two strands of research, resulting from the twin discoveries that many growth factor receptors, including EGFR, are ligand-activated receptor tyrosine kinases (RTKs), and that many retroviral transforming proteins are dysregulated tyrosine kinases that usurp RTK signalling pathways to drive continuous cell proliferation. A French translation of this abstract is available in the supplementary material. This article is part of the discussion meeting issue 'Epidermal growth factor receptor after 40 years'.

Philosophical Transactions of the Royal Society B Biological SciencesVol. 381(1957)
Salk Institute for Biological Studies (US)
Openalex Percentile: Top 13%
HER2/EGFR in Cancer Research
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.

The epidermal growth factor receptor—the prototypic RTK—turns 40 — Tony Hunter · Philosophical Transactions of the Royal Society B Biological Sciences (2026) | TGRS Research Map | TGRS